Written informed consent or equivalent document (e.g., written information) as per country regulation prior to registration of any patient data

Male or female patients aged 18 years or older with a diagnosis of Cushing's disease for whom surgery has failed or for whom surgery is not an option

Patients must be treated with pasireotide s.c. started either at the first visit for this study or prior to study entry

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease